1Klok J, Brouwer J, van Praag M. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand, 1981, 64(1): 1～11.
2Terra L, Montgomery A. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharnacol, 1998, 13(2): 55～62.
3Rapaport M, Coccaro E, Sheline Y, et al. A comparison of fluvoxamine and fluoxetine in the treatment of major depression. J Clin Psychopharmacol, 1996, 16(5): 8～373.
4Hallmans M, Timmerman L, Hoogduin A. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpationts: adouble-blind, multicentre study. The LUCIFER Group. Int Clin Psychopharmacol, 1996, 11(3): 64y～157.
5Walcaghom D, Apter T, Halikas A, et el. The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients. Am Clin Psychiatry, 1996, 8(3): 51～139.
6Claghom L, Earl Q, Walczak D, et al. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. J Clin Psychopharmacol, 1996, 16(2): 20～113.
7Fabre L, Birkimer J, Zsbomy A, et al. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients, Int Clin Psychopharmacol, 1996, 11(2): 27～119.
8Kasper S, Moller J, Montgomery A, et al. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. Int Clin Psychopharmacol, 1995, 9(Suppl 4): 3～12.
9Bougerol T, Uchida C, Gachoud P, et al. Efficacy and tolerability of mcolobemide compared with fluvoxamine in depressive disorder(DSM-Ⅲ). A French/Swiss double-blind trial. Psychopharmacology (Berl), 1992, 106(Suppl): 8～102.
10Laws D, Ashford J, Anstee A.A multicentre double-blind comparative trial of fluvoxamine versus lorszepam in mixed anxiety and depression treated in general practice, Acta Psychiatr Scand, 1990, 81(2): 9～185.
